Alnylam Pharmaceuticals I...
(ALNY)
undefined
undefined%
At close: undefined
246.57
0.54%
After-hours Dec 13, 2024, 05:28 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 |
| Net Income | -440.24M | -1.13B | -852.82M | -858.28M | -886.12M | -761.50M | -490.87M | -410.11M | -290.07M | -360.39M | -89.22M | -106.01M | -57.65M | -43.52M | -47.59M | -26.25M | -85.47M | -34.61M | -42.91M | -32.65M | -25.03M | -4.14M |
| Depreciation & Amortization | 97.03M | 85.55M | 89.69M | 74.44M | 54.37M | 6.43M | 13.37M | 15.13M | 19.05M | 11.93M | 10.23M | 9.04M | 5.13M | 4.94M | 5.99M | 5.73M | 4.08M | 3.81M | 3.12M | 2.44M | 838.00K | 36.00K |
| Stock-Based Compensation | 221.68M | 230.65M | 165.72M | 139.87M | 174.84M | 157.75M | 92.82M | 75.53M | 45.78M | 33.06M | 20.70M | 12.36M | 16.80M | 19.34M | 20.17M | 18.03M | 14.47M | 8.30M | - | 4.11M | - | - |
| Other Working Capital | -509.00K | -147.59M | -122.85M | -38.41M | 422.42M | 37.02M | 1.85M | 16.76M | 2.28M | -5.84M | -6.00M | -6.78M | -52.42M | -76.38M | -60.31M | 65.14M | 254.68M | -4.74M | - | 4.41M | - | - |
| Other Non-Cash Items | 214.93M | 309.24M | 174.24M | 95.75M | -12.61M | -6.84M | 2.91M | 1.51M | 984.00K | 221.46M | 449.00K | 364.00K | 1.08M | 3.71M | 4.86M | 9.59M | 7.12M | 8.43M | 6.55M | 7.16M | 8.46M | 172.00K |
| Deferred Income Tax | - | - | -55.70M | -54.04M | -11.29M | -3.56M | 1.89M | -6.98M | - | -42.29M | -2.69M | -22.39M | 3.50M | 10.74M | -5.16M | -5.50M | 1.89M | -7.92M | - | -4.11M | - | - |
| Change in Working Capital | 10.76M | -35.55M | -162.82M | -12.70M | 402.38M | 45.10M | -2.90M | 17.22M | 35.12M | -29.40M | -8.12M | -8.96M | -55.93M | -79.56M | -50.41M | 63.90M | 254.42M | -2.65M | 16.76M | 3.48M | 2.91M | 2.65M |
| Operating Cash Flow | 104.16M | -541.27M | -641.69M | -614.96M | -278.43M | -562.62M | -382.79M | -307.70M | -189.14M | -165.64M | -68.66M | -115.61M | -87.07M | -84.34M | -72.14M | 65.49M | 196.52M | -24.63M | -16.48M | -19.57M | -12.83M | -1.28M |
| Capital Expenditures | -62.21M | -72.06M | -76.37M | -70.36M | -140.16M | -126.89M | -104.21M | -64.56M | -12.95M | -8.96M | -4.01M | -8.35M | -1.29M | -4.73M | -4.95M | -10.76M | -7.79M | -4.99M | -1.95M | -9.01M | -3.12M | -562.00K |
| Acquisitions | - | - | - | - | - | - | - | - | - | -25.00M | - | - | -81.96M | -17.84M | -10.00M | -100.00K | 2.34M | - | 40.42M | - | -121.00K | - |
| Purchase of Investments | -1.88B | -1.98B | -1.66B | -2.03B | -2.08B | -1.10B | -903.46M | -759.31M | -1.03B | -977.77M | -364.31M | -277.13M | -293.12M | -390.47M | -481.34M | -482.24M | -554.39M | -172.30M | -70.88M | -33.50M | - | - |
| Sales Maturities Of Investments | 1.61B | 2.23B | 1.46B | 1.69B | 1.78B | 1.52B | 597.30M | 1.12B | 726.94M | 462.92M | 237.81M | 289.01M | 376.37M | 413.04M | 504.57M | 511.04M | 283.25M | 147.24M | 32.41M | 7.72M | - | - |
| Other Investing Acitivies | -4.44M | -13.19M | -4.36M | -31.20M | 23.00M | -14.82M | 120.00M | -150.00M | -1.47M | -25.00M | -126.50M | -162.00K | 81.96M | 17.84M | 6.15M | -100.00K | -839.00K | - | -40.42M | 185.00K | - | - |
| Investing Cash Flow | -336.35M | 169.35M | -273.30M | -435.52M | -417.68M | 272.94M | -290.36M | 142.59M | -321.32M | -548.81M | -130.50M | 3.37M | 81.96M | 17.84M | 14.43M | 17.94M | -277.43M | -30.05M | -40.42M | -34.59M | -3.24M | -562.00K |
| Debt Repayment | - | 254.00M | 500.00M | 200.00M | - | - | -120.00M | 150.00M | - | - | - | - | - | - | - | -6.76M | -2.38M | 1.74M | 194.00K | 5.34M | -1.10M | - |
| Common Stock Repurchased | - | - | - | - | - | -3.47M | -257.00K | -596.00K | -378.00K | -15.99M | -1.39M | -359.00K | - | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | 172.13M | 171.75M | 747.12M | 695.48M | 41.28M | 65.47M | 83.89M | 14.13M | 31.14M | 29.42M | 28.74M | 6.97M | 738.00K | 2.67M | - | - | - | - | - | 327.00K | -2.67M | -28.00K |
| Financial Cash Flow | 172.13M | 425.75M | 1.25B | 994.98M | 823.18M | 65.47M | 1.12B | 177.83M | 616.18M | 736.47M | 200.93M | 93.41M | 738.00K | 3.66M | 3.51M | 3.15M | 58.63M | 166.63M | 52.62M | 50.98M | 23.71M | 17.32M |
| Net Cash Flow | -53.67M | 46.40M | 323.11M | -50.58M | 127.00M | -224.20M | 451.74M | 12.72M | 105.72M | 22.01M | 1.76M | -18.82M | -4.37M | -62.87M | -54.32M | 86.64M | -22.80M | 112.20M | -4.51M | -2.92M | 7.72M | 17.32M |
| Free Cash Flow | 41.95M | -613.33M | -718.07M | -685.32M | -418.58M | -689.50M | -487.00M | -372.26M | -202.09M | -174.60M | -72.66M | -123.96M | -88.36M | -89.07M | -77.09M | 54.73M | 188.73M | -29.62M | -18.43M | -28.58M | -15.95M | -1.84M |